{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:06:57Z","timestamp":1768565217548,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.disamonth.2013.03.013","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T18:16:53Z","timestamp":1371579413000},"page":"261-268","source":"Crossref","is-referenced-by-count":33,"title":["The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients"],"prefix":"10.1016","volume":"59","author":[{"given":"Peter K.","family":"Sand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert I.","family":"Sand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2013.03.013_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ucl.2010.06.003","article-title":"Contemporary management of the neurogenic bladder for multiple sclerosis patients","volume":"37","author":"Stoffel","year":"2010","journal-title":"Urol Clin North Am"},{"issue":"suppl 4","key":"10.1016\/j.disamonth.2013.03.013_bib2","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1007\/s10072-008-1041-z","article-title":"Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology","volume":"29","author":"Di Benedetto","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/j.disamonth.2013.03.013_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ucl.2010.07.004","article-title":"Review of neurologic diseases for the urologist","volume":"37","author":"Fowler","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.disamonth.2013.03.013_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1053-8119(03)00117-4","article-title":"Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets","volume":"19","author":"Charil","year":"2003","journal-title":"NeuroImage"},{"issue":"Pt 6","key":"10.1016\/j.disamonth.2013.03.013_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/brain\/113.6.1597","article-title":"Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis","volume":"113","author":"Phadke","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.disamonth.2013.03.013_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jocn.2008.12.012","article-title":"Urinary dysfunction in multiple sclerosis","volume":"16","author":"Nakipoglu","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.disamonth.2013.03.013_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-5347(01)61760-9","article-title":"Multiple sclerosis and the urologist","volume":"161","author":"Litwiller","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de Seze","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.disamonth.2013.03.013_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.sc.3100337","article-title":"Urinary tract dysfunction in multiple sclerosis: is there a relation with disease-related parameters?","volume":"35","author":"Porru","year":"1997","journal-title":"Spinal Cord"},{"key":"10.1016\/j.disamonth.2013.03.013_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1520-6777(1998)17:2<89::AID-NAU2>3.0.CO;2-8","article-title":"Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients","volume":"17","author":"Giannantoni","year":"1998","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.disamonth.2013.03.013_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.urology.2004.11.038","article-title":"Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation","volume":"65","author":"Lemack","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.disamonth.2013.03.013_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0404.2008.00992.x","article-title":"Analysis of the upper urinary tract function in multiple sclerosis patients","volume":"118","author":"Krhut","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.disamonth.2013.03.013_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-5347(17)50216-5","article-title":"Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition","volume":"131","author":"Blaivas","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13813450701531227","article-title":"Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"113","author":"Tauber","year":"2007","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.disamonth.2013.03.013_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000289098","article-title":"Neurological symptoms accompanying urinary tract infections","volume":"63","author":"Hufschmidt","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.purol.2010.07.014","article-title":"Multiple sclerosis and urolithiasis","volume":"21","author":"Rached","year":"2011","journal-title":"Progres en urologiee"},{"key":"10.1016\/j.disamonth.2013.03.013_bib17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","article-title":"Cancer risk among patients with multiple sclerosis and their parents","volume":"72","author":"Bahmanyar","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2013.03.013_bib18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","article-title":"Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS patient registry","volume":"183","author":"Mahajan","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib19","first-page":"61","article-title":"Pelvic floor rehabilitation in multiple sclerosis","volume":"99","author":"De Ridder","year":"1999","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.disamonth.2013.03.013_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/nau.20209","article-title":"Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study","volume":"25","author":"McClurg","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.disamonth.2013.03.013_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20486","article-title":"Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis\u2014a double blind, placebo controlled, randomised clinical trial","volume":"27","author":"McClurg","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.disamonth.2013.03.013_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/nau.20941","article-title":"Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis","volume":"29","author":"Lucio","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.disamonth.2013.03.013_bib23","first-page":"CD004193","article-title":"Anticholinergics for urinary symptoms in multiple sclerosis","author":"Nicholas","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.disamonth.2013.03.013_bib24","doi-asserted-by":"crossref","first-page":"834753","DOI":"10.1155\/2011\/834753","article-title":"Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study","volume":"2011","author":"van Rey","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0022-5347(17)45940-4","article-title":"Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia","volume":"135","author":"Gajewski","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","article-title":"Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo","volume":"145","author":"Thuroff","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis","volume":"112","author":"Bosma","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.disamonth.2013.03.013_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00192-009-1023-6","article-title":"Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization","volume":"21","author":"Marinkovic","year":"2010","journal-title":"Int Urogynecol J"},{"issue":"96","key":"10.1016\/j.disamonth.2013.03.013_bib30","first-page":"e1","article-title":"Sacral nerve neuromodulation in patients with underlying neurologic disease","volume":"197","author":"Wallace","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/nau.20170","article-title":"Event driven electrical stimulation of the dorsal penile\/clitoral nerve for management of neurogenic detrusor overactivity in multiple sclerosis","volume":"25","author":"Fjorback","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.disamonth.2013.03.013_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/nau.20958","article-title":"Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study","volume":"30","author":"de Seze","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.disamonth.2013.03.013_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.sc.3100505","article-title":"The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results","volume":"36","author":"Wiart","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.disamonth.2013.03.013_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2005.04.012","article-title":"Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial","volume":"48","author":"Silva","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ju.0000100385.93801.d4","article-title":"Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study","volume":"171","author":"de Seze","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10790268.2008.11760706","article-title":"Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects","volume":"31","author":"MacDonald","year":"2008","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.disamonth.2013.03.013_bib37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2010.05.035","article-title":"The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study","volume":"184","author":"Mehnert","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib42","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib43","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.juro.2010.12.002","article-title":"Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis","volume":"185","author":"Khan","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib45","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.disamonth.2013.03.013_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-3-642-16499-6_20","article-title":"Cannabinoids: potential targets for bladder dysfunction","author":"Ruggieri","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.disamonth.2013.03.013_bib47","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2013.03.013_bib48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","article-title":"The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)","volume":"17","author":"Freeman","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.disamonth.2013.03.013_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","article-title":"An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis","volume":"10","author":"Brady","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.disamonth.2013.03.013_bib50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp.2008.159178","article-title":"A UK consensus on the management of the bladder in multiple sclerosis","volume":"85","author":"Fowler","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.disamonth.2013.03.013_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1179\/joc.2010.22.1.36","article-title":"Effects of antimicrobial prophylaxis on asymptomatic bacteriuria and predictors of failure in patients with multiple sclerosis","volume":"22","author":"Fakas","year":"2010","journal-title":"J Chemother"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502913000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502913000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T20:21:59Z","timestamp":1563222119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502913000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0011502913000667"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2013.03.013","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}